Healthcare Services

Antimicrobial Susceptibility Testing Market Developments and Growth Opportunities Across 2026–2030

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Antimicrobial Susceptibility Testing Market From 2026 To 2030?

The antimicrobial susceptibility testing market has experienced substantial growth in recent years. It is projected to increase from $4.65 billion in 2025 to $4.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.0%. This historical expansion can be attributed to the escalating incidence of infectious diseases, rising awareness concerning antimicrobial resistance, the expansion of clinical microbiology laboratories, greater volumes of hospital diagnostic testing, and the availability of standardized AST protocols.

The antimicrobial susceptibility testing market is anticipated to experience substantial expansion in the coming years. By 2030, this market is projected to reach $6.01 billion, demonstrating a compound annual growth rate (CAGR) of 5.1%. This projected growth during the forecast period stems from factors such as heightened investments in quick diagnostic technologies, the increasing use of AI-supported laboratory analysis, the broadening of antimicrobial resistance surveillance initiatives, an escalating need for point-of-care AST solutions, and a greater emphasis on precise antimicrobial treatment. Key trends expected over the forecast horizon encompass a greater uptake of automated AST systems, an increasing need for rapid diagnostic tests, enhanced integration of molecular and phenotypic techniques, the proliferation of laboratory automation solutions, and a sharpened focus on monitoring antimicrobial resistance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4026&type=smp

What Major Drivers Are Influencing Demand In The Antimicrobial Susceptibility Testing Market?

The global increase in the prevalence of infectious diseases has significantly contributed to the expansion of the antimicrobial susceptibility testing market. These diseases are triggered by microorganisms such as bacteria, viruses, fungi, and parasites. Examples include bacterial pneumonia and tuberculosis, which are caused by bacteria, and viral infections like smallpox and AIDS. For instance, in March 2024, the Centers for Disease Control and Prevention, a US-based national public health agency, reported that in 2023, out of 9,573 tuberculosis cases where birth origin was identified, 7,259 (76%) involved non-U.S.–born individuals. This represented an 18% increase compared to the 6,177 cases of this type recorded in 2022. Thus, the growing frequency of infectious diseases is a key factor driving the growth of the antimicrobial susceptibility testing market.

Which Segments Are Included In The Analysis Of The Antimicrobial Susceptibility Testing Market?

The antimicrobial susceptibility testing market covered in this report is segmented –

1) By Testing Type: Antibacterial Testing, Antifungal Testing, Antiparasitic Testing, Other Testing Types

2) By Product: Manual Antimicrobial Susceptibility Testing Products, Automated Laboratory Instruments, Consumables

3) By Application: Diagnostics, Drug Discovery and Development, Epidemiology, Other Applications

4) By End User: Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Companies, Research And Academic Institutes, Clinical Research Organizations (CROs)

Subsegments:

1) By Antibacterial Testing: Disk Diffusion Method, Broth Dilution Method, E-Test Method, Automated Systems

2) By Antifungal Testing: Broth Dilution Method, Agar Disk Diffusion Method, E-Test Method, Colorimetric Methods

3) By Antiparasitic Testing: In vitro Susceptibility Testing, Microscopic Examination, Molecular Methods

4) By Other Testing Types: Mycobacterial Susceptibility Testing, Biofilm Susceptibility Testing, Combination Antimicrobial Testing

What Major Market Trends Are Driving Changes In The Antimicrobial Susceptibility Testing Market?

Leading firms within the antimicrobial susceptibility testing market are creating novel products, for example, the First POC Testing System. This system identifies the presence or absence of bacteria and evaluates antimicrobial efficacy by utilizing urine specimens from individuals with suspected urinary tract infections (UTIs). It represents a notable advancement in AST technologies, aiding in the quicker commencement of focused antimicrobial treatment for infected patients. As an illustration, in June 2023, Sysmex Corporation, a Japan-based enterprise known for producing reagents and equipment for clinical examinations, including hematologic (blood) and immune tests, introduced a testing system designed for swift antimicrobial susceptibility detection. Employing its unique and proprietary microfluidic technology, this system provides antimicrobial susceptibility testing (AST) outcomes in as brief as 30 minutes from measurement initiation, marking a substantial decrease from the several days typically needed for traditional AST.

Which Key Industry Participants Are Active In The Antimicrobial Susceptibility Testing Market?

Major companies operating in the antimicrobial susceptibility testing market are BioMérieux SA, Becton Dickinson and Company, Thermo Fisher Scientific Inc., Danaher Corporation, Bio-Rad Laboratories Inc., Accelerate Diagnostics Inc., Alifax Holding S.p.A., Synbiosis Ltd., Mast Group Ltd., ELITechGroup, Genefluidics Inc., QuantaMatrix Inc., Bruker Corporation, Eurofins Scientific SE, Liofilchem s.r.l., Hardy Diagnostics, Bioanalyse GmbH, Lab M Limited, Microbiologics Inc., Quidel Corporation, R-Biopharm AG, SSI Diagnostica A/S

Read the full antimicrobial susceptibility testing market report here:

https://www.thebusinessresearchcompany.com/report/antimicrobial-susceptibility-testing-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Antimicrobial Susceptibility Testing Market?

North America was the largest region in the antimicrobial susceptibility testing market in 2025. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the antimicrobial susceptibility testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Antimicrobial Susceptibility Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=4026&type=smp

Browse Through More Reports Similar to the Global Antimicrobial Susceptibility Testing Market 2026, By The Business Research Company

Antimicrobial Medical Device Coatings Global Market Report

https://www.thebusinessresearchcompany.com/report/antimicrobial-medical-device-coatings-global-market-report

Multidrug Resistant Bacteria Global Market Report

https://www.thebusinessresearchcompany.com/report/multidrug-resistant-bacteria-global-market-report

Genotyping Assay Global Market Report

https://www.thebusinessresearchcompany.com/report/genotyping-assay-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795